• to lessen the risk of major cardiovascular (coronary heart and blood vessel) difficulties in Grown ups with variety two diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss capsule in Could but remains hoping for the slice of the market with MariTide, a regular injection that may be